Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Hidalgo

Showing results (191-200 of 385) with videos related to

Pageof 39
Sort By:
Journal of Medicinal Chemistry|September 10, 2008
Novel microtubule-interacting phenoxy pyridine and phenyl sulfanyl pyridine analogues for cancer therapyRavi Kumar Anchoori, Madeleine Susanne Quirine Kortenhorst, Manuel Hidalgo, et al.
Marine Environmental Research|April 9, 2024
Understanding the response of the Western Mediterranean cephalopods to environment and fishing in a context of alleged winners of changeCarlos Veloy, Marta Coll, Maria Grazia Pennino, et al.
Scientific Reports|June 2, 2026
Evidence of within- and between-stock connectivity in Mediterranean fisheries challenges the stock unit paradigmGeorgios Kerametsidis, Manuel Hidalgo, Baptiste Mourre, et al.
World Journal of Gastroenterology|August 3, 2010
Approach to early-onset colorectal cancer: clinicopathological, familial, molecular and immunohistochemical characteristicsJose Perea, Edurne Alvaro, Yolanda Rodríguez, et al.
Pediatric Blood & Cancer|January 21, 2006
Analysis of biologic surrogate markers from a Children's Oncology Group Phase I trial of gefitinib in pediatric patients with solid tumorsAntonio Jimeno, Najat C Daw, Maria L Amador, et al.
Molecular Cancer Therapeutics|May 8, 2007
Development of two novel benzoylphenylurea sulfur analogues and evidence that the microtubule-associated protein tau is predictive of their activity in pancreatic cancerAntonio Jimeno, Gurulingappa Hallur, Audrey Chan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2009
[18F]fluorodeoxyglucose positron emission tomography correlates with Akt pathway activity but is not predictive of clinical outcome during mTOR inhibitor therapyWen Wee Ma, Heather Jacene, Dongweon Song, et al.
Ecological Applications : a Publication of the Ecological Society of America|May 31, 2019
Accounting for ocean connectivity and hydroclimate in fish recruitment fluctuations within transboundary metapopulationsManuel Hidalgo, Vincent Rossi, Pedro Monroy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2011
MK-1775, a potent Wee1 inhibitor, synergizes with gemcitabine to achieve tumor regressions, selectively in p53-deficient pancreatic cancer xenograftsN V Rajeshkumar, Elizabeth De Oliveira, Niki Ottenhof, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Immunohistochemical and genetic evaluation of deoxycytidine kinase in pancreatic cancer: relationship to molecular mechanisms of gemcitabine resistance and survivalValeria Sebastiani, Francesca Ricci, Belen Rubio-Viqueira, et al.
Pageof 39

Showing results (191-200 of 385) with videos related to

Sort By:
Pageof 39
Journal of Medicinal Chemistry|September 10, 2008
Novel microtubule-interacting phenoxy pyridine and phenyl sulfanyl pyridine analogues for cancer therapyRavi Kumar Anchoori, Madeleine Susanne Quirine Kortenhorst, Manuel Hidalgo, et al.
Marine Environmental Research|April 9, 2024
Understanding the response of the Western Mediterranean cephalopods to environment and fishing in a context of alleged winners of changeCarlos Veloy, Marta Coll, Maria Grazia Pennino, et al.
Scientific Reports|June 2, 2026
Evidence of within- and between-stock connectivity in Mediterranean fisheries challenges the stock unit paradigmGeorgios Kerametsidis, Manuel Hidalgo, Baptiste Mourre, et al.
World Journal of Gastroenterology|August 3, 2010
Approach to early-onset colorectal cancer: clinicopathological, familial, molecular and immunohistochemical characteristicsJose Perea, Edurne Alvaro, Yolanda Rodríguez, et al.
Pediatric Blood & Cancer|January 21, 2006
Analysis of biologic surrogate markers from a Children's Oncology Group Phase I trial of gefitinib in pediatric patients with solid tumorsAntonio Jimeno, Najat C Daw, Maria L Amador, et al.
Molecular Cancer Therapeutics|May 8, 2007
Development of two novel benzoylphenylurea sulfur analogues and evidence that the microtubule-associated protein tau is predictive of their activity in pancreatic cancerAntonio Jimeno, Gurulingappa Hallur, Audrey Chan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2009
[18F]fluorodeoxyglucose positron emission tomography correlates with Akt pathway activity but is not predictive of clinical outcome during mTOR inhibitor therapyWen Wee Ma, Heather Jacene, Dongweon Song, et al.
Ecological Applications : a Publication of the Ecological Society of America|May 31, 2019
Accounting for ocean connectivity and hydroclimate in fish recruitment fluctuations within transboundary metapopulationsManuel Hidalgo, Vincent Rossi, Pedro Monroy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2011
MK-1775, a potent Wee1 inhibitor, synergizes with gemcitabine to achieve tumor regressions, selectively in p53-deficient pancreatic cancer xenograftsN V Rajeshkumar, Elizabeth De Oliveira, Niki Ottenhof, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Immunohistochemical and genetic evaluation of deoxycytidine kinase in pancreatic cancer: relationship to molecular mechanisms of gemcitabine resistance and survivalValeria Sebastiani, Francesca Ricci, Belen Rubio-Viqueira, et al.
Pageof 39